Literature DB >> 9209655

The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.

D M Knowles1, E Cesarman.   

Abstract

BACKGROUND: Two novel nonhuman DNA fragments were discovered in an AIDS-related Kaposi's sarcoma (KS) lesion using representational difference analysis.
DESIGN: These sequences belong to a previously unidentified gamma-2-herpesvirus exhibiting homology with Herpesvirus saimiri and Epstein-Barr virus. This virus was named Kaposi's sarcoma-associated herpesvirus (KSHV) and provisionally designated human herpesvirus-8 (HHV-8).
RESULTS: KSHV is detectable in more than 90% of classical-Mediterranean, iatrogenic, endemic-African, and AIDS-epidemic KS lesions. In situ PCR studies have demonstrated KSHV in the spindle cells and endothelial cells of KS lesions. KSHV appears to be a transmissible B-lymphotropic herpesvirus. It is detectable in circulating B cells in some HIV-infected patients, and this finding appears to predict the future development of KS among these individuals. KSHV has been identified in a rare and distinct subset of malignant lymphoma referred to as body cavity-based lymphoma but not in other lymphoid neoplasms. KSHV is absent from most other HIV- and non-HIV-associated lymphadenopathies.
CONCLUSIONS: Further studies should lead to a better understanding of the role of KSHV in the pathogenesis of these disorders and may eventually show that KSHV represents the long sought-after etiologic agent of Kaposi's sarcoma.

Entities:  

Mesh:

Year:  1997        PMID: 9209655

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  7 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients.

Authors:  For Yue Tso; Ashley Sawyer; Eun Hee Kwon; Victor Mudenda; Dianne Langford; You Zhou; John West; Charles Wood
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

2.  Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.

Authors:  Francesca Curreli; Francesca Cerimele; Sumitra Muralidhar; Leonard J Rosenthal; Ethel Cesarman; Alvin E Friedman-Kien; Ornella Flore
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 3.  CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas.

Authors:  Alexandra S Onea; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

4.  Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation.

Authors:  A Matolcsy; R G Nádor; E Cesarman; D M Knowles
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

5.  RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism.

Authors:  For Yue Tso; Andrew V Kossenkov; Salum J Lidenge; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Jayamanna Wickramasinghe; Eun Hee Kwon; John T West; Paul M Lieberman; Charles Wood
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

6.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

Review 7.  Transfusion-transmitted infections.

Authors:  Florian Bihl; Damiano Castelli; Francesco Marincola; Roger Y Dodd; Christian Brander
Journal:  J Transl Med       Date:  2007-06-06       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.